New research has unveiled a hidden superpower of the popular weight-loss drug Tirzepatide, sold commercially as Mounjaro and Zepbound. Scientists discovered that the medication directly activates calorie-burning brown adipose tissue (brown fat) in obese models. This breakthrough reveals a potent metabolic effect that works independently of appetite suppression, shedding new light on how modern weight management therapies can fundamentally accelerate metabolic rates and improve overall metabolic health.
About the Author
